You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 3, March 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Use of Psychostimulants in General Psychiatry

A Reconsideration

Robert J. Chiarello, MD; Jonathan O. Cole, MD

Arch Gen Psychiatry. 1987;44(3):286-295.


Abstract

• A half century after the introduction of amphetamine sulfate (benzedrine), there remains active interest in the use of the major psychostimulants (ie, methylphenidate hydrochloride and pemoline) for the treatment of psychiatric disorders. In the absence of any recent review of the literature on the clinical uses of psychostimulants, we assessed the existing data on the adult psychiatric indications for these agents. Generally, the existing studies are old and inadequate. However, there is some evidence to support the judicious use of psychostimulants in selected clinical instances of several adult psychiatric syndromes.



Author Affiliations

From the McLean Hospital, Belmont, Mass.


Footnotes

Accepted for publication April 10, 1986.

Reprint requests to McLean Hospital, Belmont, MA 02178 (Dr Cole).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Beyond ADHD and narcolepsy: psychostimulants in general psychiatry
Ng and O'Brien
Adv. Psychiatr. Treat. 2009;15:297-305.
ABSTRACT | FULL TEXT  

Methylphenidate Treats Apathy in Parkinson's Disease
CHATTERJEE and FAHN
J. Neuropsychiatry Clin. Neurosi. 2002;14:461-462.
FULL TEXT  

Depression in palliative care: a systematic review. Part 2. Treatment
Ly et al.
Palliat Med 2002;16:279-284.
ABSTRACT  

Palliative Uses of Methylphenidate in Patients With Cancer: A Review
Rozans et al.
JCO 2002;20:335-339.
ABSTRACT | FULL TEXT  

Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman et al.
JAMA 1998;279:1100-1107.
ABSTRACT | FULL TEXT  

Good Care of the Dying Patient
Council on Scientific Affairs, American Medical As et al.
JAMA 1996;275:474-478.
ABSTRACT  

The Role of Methylphenidate in Psychiatry
Klein and Wender
Arch Gen Psychiatry 1995;52:429-433.
ABSTRACT  

Prescription Drug Diversion Control and Medical Practice
Cooper et al.
JAMA 1992;268:1306-1310.
ABSTRACT  

Low-Dose Methylphenidate in the Very Old
Gurian and Rosowsky
J Geriatr Psychiatry Neurol 1990;3:152-154.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.